Skip to main content
NCBI home page
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1992 May;49(5):359–364. doi: 10.1136/oem.49.5.359

Scintigraphy with J001X, a Klebsiella membrane glycolipid, for the early diagnosis of chronic berylliosis: results from an experimental model.

P Diot 1, A Le Pape 1, D Nolibe 1, G Normier 1, H Binz 1, J P Revillard 1, G Lasfargues 1, M Lavandier 1, E Lemarié 1
PMCID: PMC1039255  PMID: 1599873

Abstract

A glycolipid (J001X) isolated from the membrane proteoglycans of a non-pathogenic strain of Klebsiella pneumoniae was developed to bind selectively to macrophages. A scintigraphic technique could thus be developed and applied to an experimental model of lung berylliosis. Six baboons were injected intratracheally with a beryllium metal suspension. Three to 24 months later, they were submitted to both an anatomical and a functional respiratory evaluation. Two baboons were explored at the early stage of alveolitis and four baboons at a more advanced stage characterised by a granulomatous disorder. Scintigraphy was performed using J001X labelled with 99mtechnetium administered as an aerosol. In the six baboons, conventional imaging techniques (chest x ray film, computed tomography scan, gallium scintigraphy), failed to show either any lung abnormality or mediastinal lymph nodes consistent with beryllium disease. In the two recently contaminated baboons, J001X scintigraphy showed a well defined parenchymal fixation facing the contaminated lobe. In the four baboons who were at a more advanced stage of berylliosis, J001X fixation was always focused paratracheally without any significant involvement of the lung parenchyma. The subcarinal and laterotracheal lymph nodes seen at necropsy corresponded to J001X scintigraphic fixations. In conclusion, when compared with conventional techniques such as chest x ray film, computed tomography scan, magnetic resonance imaging, and gallium scintigraphy, J001X scintigraphy has proved its ability to detect occult lesions in experimental berylliosis in baboons. By comparison with gallium scintigraphy, scintigraphy with J001X appears to have superior sensitivity and can be performed in four hours.

Full text

PDF
359

Images in this article

361Image
on p.361
362Image
on p.362

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Daniele R. P. Cell-mediated immunity in pulmonary disease. Hum Pathol. 1986 Feb;17(2):154–160. doi: 10.1016/s0046-8177(86)80288-x. [DOI] [PubMed] [Google Scholar]
  2. Daniele R. P., Elias J. A., Epstein P. E., Rossman M. D. Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease. Ann Intern Med. 1985 Jan;102(1):93–108. doi: 10.7326/0003-4819-102-1-93. [DOI] [PubMed] [Google Scholar]
  3. Deodhar S. D., Barna B., Van Ordstrand H. S. A study of the immunologic aspects of chronic berylliosis. Chest. 1973 Mar;63(3):309–313. doi: 10.1378/chest.63.3.309. [DOI] [PubMed] [Google Scholar]
  4. Eisenbud M. Origins of the standards for control of beryllium disease (1947-1949). Environ Res. 1982 Feb;27(1):79–88. doi: 10.1016/0013-9351(82)90059-7. [DOI] [PubMed] [Google Scholar]
  5. Epstein P. E., Dauber J. H., Rossman M. D., Daniele R. P. Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann Intern Med. 1982 Aug;97(2):213–216. doi: 10.7326/0003-4819-97-2-213. [DOI] [PubMed] [Google Scholar]
  6. Hanifin J. M., Epstein W. L., Cline M. J. In vitro studies on granulomatous hypersensitivity to beryllium. J Invest Dermatol. 1970 Oct;55(4):284–288. doi: 10.1111/1523-1747.ep12260036. [DOI] [PubMed] [Google Scholar]
  7. Hardy H. L. Beryllium disease: a clinical perspective. Environ Res. 1980 Feb;21(1):1–9. doi: 10.1016/0013-9351(80)90002-x. [DOI] [PubMed] [Google Scholar]
  8. Kang K. Y., Bice D., D'Amato R., Ziskind M., Salvaggio J. Effects of asbestos and beryllium on release of alveolar macrophage enzymes. Arch Environ Health. 1979 May-Jun;34(3):133–140. doi: 10.1080/00039896.1979.10667384. [DOI] [PubMed] [Google Scholar]
  9. Kriebel D., Brain J. D., Sprince N. L., Kazemi H. The pulmonary toxicity of beryllium. Am Rev Respir Dis. 1988 Feb;137(2):464–473. doi: 10.1164/ajrccm/137.2.464. [DOI] [PubMed] [Google Scholar]
  10. Price C. D., Pugh A., Pioli E. M., Williams W. J. Beryllium macrophage migration inhibition test. Ann N Y Acad Sci. 1976;278:204–211. doi: 10.1111/j.1749-6632.1976.tb47031.x. [DOI] [PubMed] [Google Scholar]
  11. Rinderknecht J., Shapiro L., Krauthammer M., Taplin G., Wasserman K., Uszler J. M., Effros R. M. Accelerated clearance of small solutes from the lungs in interstitial lung disease. Am Rev Respir Dis. 1980 Jan;121(1):105–117. doi: 10.1164/arrd.1980.121.1.105. [DOI] [PubMed] [Google Scholar]
  12. Saltini C., Winestock K., Kirby M., Pinkston P., Crystal R. G. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med. 1989 Apr 27;320(17):1103–1109. doi: 10.1056/NEJM198904273201702. [DOI] [PubMed] [Google Scholar]
  13. Sprince N. L., Kanarek D. J., Weber A. L., Chamberlin R. I., Kazemi H. Reversible respiratory disease in beryllium workers. Am Rev Respir Dis. 1978 Jun;117(6):1011–1017. doi: 10.1164/arrd.1978.117.6.1011. [DOI] [PubMed] [Google Scholar]
  14. Williams W. J., Williams W. R. Value of beryllium lymphocyte transformation tests in chronic beryllium disease and in potentially exposed workers. Thorax. 1983 Jan;38(1):41–44. doi: 10.1136/thx.38.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Williams W. R., Williams W. J. Comparison of lymphocyte transformation and macrophage migration inhibition tests in the detection of beryllium hypersensitivity. J Clin Pathol. 1982 Jun;35(6):684–687. doi: 10.1136/jcp.35.6.684. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES